Yasuo Kurimoto Selected Research

Yasuo Kurimoto Research Topics

Disease

18	Macular Degeneration (Age-Related Maculopathy) 04/2021 - 09/2007
12	Polypoidal Choroidal Vasculopathy 10/2019 - 09/2007
5	Cataract (Cataracts) 01/2022 - 06/2005
5	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2022 - 07/2009
4	Macular Edema 09/2017 - 10/2005
4	Retinal Detachment (Retinal Detachments) 01/2017 - 11/2002
3	Myopia 01/2022 - 08/2008
3	Glaucoma 01/2022 - 09/2006
3	Choroidal Neovascularization 10/2019 - 01/2012
3	Pain (Aches) 10/2017 - 11/2009
3	Retinal Vein Occlusion 01/2017 - 10/2005
3	Chronic Limb-Threatening Ischemia 01/2014 - 11/2009
2	Epiretinal Membrane (Epiretinal Membranes) 07/2021 - 04/2012
2	Scotoma (Scintillating Scotoma) 03/2020 - 09/2007
2	Atrophy 01/2019 - 03/2018
2	Peripheral Arterial Disease 10/2012 - 11/2009
2	Ischemia 10/2012 - 11/2009
2	Thromboangiitis Obliterans (Buerger's Disease) 10/2012 - 11/2009
1	Disease Progression 01/2022
1	Vision Disorders (Hemeralopia) 07/2021
1	Mydriasis 05/2021
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 05/2021
1	Infections 03/2020
1	Retinitis 03/2020
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 03/2018
1	Keratitis 10/2017
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Scleritis (Episcleritis) 12/2012
1	Inflammation (Inflammations) 12/2012
1	Ulcer 11/2009
1	Retinal Neovascularization 07/2009
1	Retinal Perforations 08/2008
1	Papilledema 05/2006
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 04/2005
1	Retinal Degeneration 11/2004
1	Wounds and Injuries (Trauma) 08/2003
1	Optic Nerve Injuries 08/2003

Drug/Important Bio-Agent (IBA)

11	Retinaldehyde (Retinal)IBA 07/2021 - 08/2003
10	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 09/2007
5	Ranibizumab (Lucentis)FDA Link 01/2019 - 02/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 11/2011
3	Retinal Pigments (Pigments, Visual)IBA 04/2020 - 01/2017
3	SteroidsIBA 03/2020 - 12/2012
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014 - 11/2009
2	Melanins (Melanin)IBA 01/2022 - 11/2020
2	Verteporfin (Visudyne)FDA Link 05/2014 - 10/2013
1	Therapeutic UsesIBA 01/2022
1	Ophthalmic Solutions (Eye Drops)IBA 01/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 05/2021
1	cytoplasmic protein A (PACD)IBA 05/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 10/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2018
1	Betamethasone (Celestone)FDA Link 01/2018
1	Carbonic Anhydrase InhibitorsIBA 01/2018
1	afliberceptIBA 01/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2016
1	Bevacizumab (Avastin)FDA Link 11/2015
1	HDL CholesterolIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2012
1	Infliximab (Remicade)FDA Link 12/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2012
1	Pharmaceutical PreparationsIBA 12/2012
1	pigment epithelium-derived factorIBA 07/2011
1	Oxygen (Dioxygen)IBA 11/2009
1	Pain-FreeIBA 11/2009
1	Triamcinolone (Aristocort)FDA Link 07/2009
1	Methanol (Carbinol)IBA 05/2006
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 10/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2002

Therapy/Procedure

10	Photochemotherapy (Photodynamic Therapy) 01/2019 - 09/2007
9	Therapeutics 04/2021 - 11/2011
7	Transplantation 01/2022 - 11/2004
5	Vitrectomy 09/2017 - 11/2002
4	Lasers (Laser) 03/2018 - 06/2005
3	Phacoemulsification 01/2022 - 01/2017
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2014 - 11/2009
2	Intraocular Lens Implantation 01/2022 - 01/2017
2	Intraocular Lenses (Intraocular Lens) 01/2021 - 06/2010
2	Transjugular Intrahepatic Portasystemic Shunt 02/2013 - 04/2012
2	Cell Transplantation 10/2012 - 11/2009
2	Injections 11/2011 - 10/2005
1	Intravitreal Injections 02/2013
1	Surgical Amputation (Amputations) 10/2012
1	Retreatment 07/2011